La chaîne d'options affiche les données clés des options sur actions de Aardvark Therapeutics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Aardvark Therapeutics..

Aardvark Therapeutics (NASDAQ:AARD) Stock, Chaîne d'Options

AARDVARK THERAPEUTICS INC

Aardvark Therapeutics

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) shares are trading higher. The company announced it will issue a one-time special stock dividend later this month.
What To Know: ClearOne on Tuesday said its board of directors declared a one-time special stock dividend tied to the potential sale of all or substantially all of the company's assets and operations.
The dividend will be issued in the form of one share of Class A Redeemable Preferred Stock for every outstanding share of common stock and equivalent. Upon completion of any asset sale, the preferred stock will be redeemed for 100% of the net proceeds.
The company said the dividend is part of its ongoing strategic process and ClearOne plans to pursue one or more asset sale transactions.
The dividend will be payable on July 18 to shareholders of record as of July 11.
Related Link: <a href="https://www.benzinga.com/etfs/new-etfs/25/07/46203728/quantum-ai-nuclear-three-frontiers-one-launchpad-powered-by-defiance-etfs">Quantum, AI, Nuclear: Three Frontiers, One Launchpad Powered By Defiance ETFs</a>
CLRO Price Action: At the time of writing, ClearOne stock is trading 93.9% higher at $11.15, according to data from <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/pro/&amp;ved=2ahUKEwiW08bSoZyOAxWxMlkFHQQCGE8QFnoECA8QAQ&amp;usg=AOvVaw0xIsPvjIcIIsWev01-6zR2">Benzinga Pro</a>.
Image: This illustration was generated using artificial intelligence via Midjourney.

News

Movers

CLRO

ClearOne (CLRO) Stock Is Soaring Tuesday: Here's Why

Last week, semiconductor giant Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) released its <a href="https://www.benzinga.com/markets/earnings/25/06/46104401/micron-q3-earnings-revenue-eps-beat-estimates-data-center-revenue-guidance-ai-demand">financial results for the third quarter</a> of fiscal 2025, to bullish investors' delight. Revenue landed at $9.3 billion, easily beating the consensus estimate of $8.87 billion. Further, the company smoked Wall Street's estimate for earnings per share of $1.60 by delivering an adjusted print of $1.91. Of course, the "problem" here for MU stock is that the good news is now baked in.
However, Tuesday's price action likely had speculators thinking. In the afternoon session, MU stock found itself down about 2%. That's not a particularly enticing discount if you're playing the long game. However, if you're exclusively focused on the short game — specifically through options trading — a 2% move can be an enticing event. That's because options essentially represent a market for the market, where lower-cost premiums provide enhanced leverage.
Naturally, there's a risk in bidding up a security that has already had a strong run on well-known catalysts. Still, there's fundamental evidence that the latest dip in MU stock could be temporary. First, according to the National Institute of Standards and Technology, Micron is the <a href="https://www.nist.gov/news-events/news/2025/06/president-trump-secures-200b-investment-micron-technology-memory-chip#:~:text=Micron%20is%20the%20only%20U.S.,overseas%2C%20primarily%20in%20East%20Asia.">only</a> U.S.-based manufacturer of advanced memory chips. This fact makes the semiconductor specialist strategically important, aligning with President Donald Trump's <a href="https://www.benzinga.com/markets/equities/25/06/45740017/tsmc-ceo-tells-trump-100-billion-us-chip-expansion-will-take-time-amid-tariff-pressures-surging-ai-demand">efforts to promote U.S. leadership in tech</a>.
Most importantly, Micron is straight-up critical for the deployment of artificial intelligence. As a specialist in manufacturing memory and storage chips — specifically DRAM and NAND flash — the company plays a vital role in AI infrastructure. Given that machine intelligence and its subsets are <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46079632/bofa-sees-155-billion-agentic-ai-boom-by-2030-spotlights-microsoft-salesforce-and-others">forecasted to see stratospheric growth</a>, Micron operates on very fertile ground.
Subsequently, while there's a risk that MU stock could fall back on prior support levels at $100, there's also a fundamental case that the latest splashing of red ink could be ephemeral.
<h2 class="wp-block-heading">Using Blackjack To Solidify A Bullish Strategy For MU Stock</h2>
Now, as much as one may sift through the fundamentals or draw endless scribbles on the technical chart, the harsh reality is that both approaches lack specificity. Options traders require a thesis to cover not only the magnitude component (x-axis) of an asset but also the time element (y-axis). Being right on one and missing on the other leads to a busted transaction.
To improve the odds of success, we can take a page out of the blackjack playbook, specifically the concept of card counting. Professional blackjack players will keep a running count (in their heads of course) of the ratio between high cards and low cards that have already been played. The idea is to bet large when the odds favor the better and bet minimally when the odds favor the dealer.
However, in order to establish the advantage and the magnitude of said advantage, the blackjack player must calculate two types of probabilities: derivative and conditional. Derivative probabilities establish the baseline odds for the player, otherwise known as the <a href="https://www.asc.ohio-state.edu/gan.1/teaching/spring04/Chapter3.pdf">Gaussian</a> framework. But when given a particular hand, the player applies conditional probabilities, or a <a href="https://www.stat.cmu.edu/~cshalizi/754/notes/lecture-09.pdf">Markovian</a> framework, to understand whether that hand provides an advantage over baseline.
Still, this is where I would estimate that 99.99% of financial experts get tripped up: conditional probabilities cannot be calculated using continuous scalar signals. There's a reason why card counters separate individual cards into only three categories: negative value, neutral value, positive value.
Only by converting scalar signals into discrete events can we transition from Gaussian principles to the all-important Markovian principles. That's the core reason why I no longer look at price but at market breadth or sequences of accumulative and distributive sessions.
At the moment, the trailing two months of price action for MU stock can be converted as a "7-3-U" sequence: seven up weeks, three down weeks, with a positive trajectory across the 10-week period. Similar to a blackjack player, I don't care what the individual card number or price is; I just need to know whether the market made a decision to buy or to sell.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01150414/MU-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-969209" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01150414/MU-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01150414/MU-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01150414/MU-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01150414/MU-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
By converting MU's price discovery process into (predominantly) binary sequences, we can identify that since January 2019, the stock flashed the 7-3-U sequence 27 times. In 62.96% of cases, the following week's price action results in upside, with a median return of 2.19%.
Based on past analogs, if the bulls maintain control of the market for the next three weeks, MU stock could potentially push toward the $125 level.
<h2 class="wp-block-heading">Taking What The Dealer Will Give</h2>
Based on the hand that we've been dealt, I'm intrigued by the 122/124 bull call spread expiring July 25. This transaction involves buying the $122 call and simultaneously selling the $124 call, for a net debit paid of $95, the most that can be lost in the trade. Should MU stock rise through the short strike price at expiration, the maximum reward is $105, a payout of roughly 111%.
With the above trade, you have about four weeks for the bullish thesis to pan out, giving you a cushion to account for the chaos inherent in open systems. Just as importantly, the Markovian edge gives you a statistical advantage over the Gaussian distribution. As a baseline, the chance that MU stock will rise on any given week is only 51.18%.
To be clear, we're still dealing with probabilities, not certainties. Further, the stock market's open system means that random, unpredictable events can always disrupt the paradigm from expected norms. No model can fully account for this chaos. However, most options calculators are based purely off Gaussian principles, making them aesthetically beautiful but functionally worthless. By converting to Markovian frameworks, we give ourselves a fighting chance.
The opinions and views expressed in this content are those of the individual author and do not necessarily reflect the views of Benzinga. Benzinga is not responsible for the accuracy or reliability of any information provided herein. This content is for informational purposes only and should not be misconstrued as investment advice or a recommendation to buy or sell any security. Readers are asked not to rely on the opinions or information herein, and encouraged to do their own due diligence before making investing decisions.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/options/25/06/46180165/paas-stock-silver-demand-reassess-market-risk">Options Corner: Pan American Silver May Shine Again As The Market Reassesses Risk</a></li>
</ul>
Photo: Shutterstock

Equities

Long Ideas

Options

Options Corner: Micron Traders Are Dealt A Statistical Hand Worth Playing

WIIM

BALY

Bally's shares are trading higher after Intralot announced it will acquire the company's international interactive business in a €2.7 billion cash-and-shares deal.

<a href="https://www.cnbc.com/2025/07/01/figma-fig-files-for-ipo-as-tech-debuts-gain-steam.html" title="https://www.cnbc.com/2025/07/01/figma-fig-files-for-ipo-as-tech-debuts-gain-steam.html">https://www.cnbc.com/2025/07/01/figma-fig-files-for-ipo-as-tech-debuts-gain-steam.html</a>

IPOs

'Figma Files For NYSE Debut As Tech IPO Market Gains Steam' - CNBC

Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) shares are trading higher Tuesday after the company announced its subsidiary will launch a <a href="chttps://www.benzinga.com//node/46190102">decentralized cryptocurrency exchange</a>.
What To Know: Hyperscale Data on Tuesday said its indirect wholly owned subsidiary, Ault Markets, plans to launch a decentralized cryptocurrency exchange (DEX) headquartered in Las Vegas.
The company said the platform will enable non-custodial, peer-to-peer digital asset trading with no centralized intermediary. Ault Markets expects to support trading in up to 175 countries, offering multi-chain interoperability, decentralized identity integration and Layer-2 scaling for high-speed, low-cost transactions.
The DEX is expected to go live in early 2026, following global node deployment and a smart contract audit.
&#8220;We believe it is time for the United States to take the lead in the digital asset space,&#8221; said Milton Ault III, founder and executive chairman of Hyperscale Data. 
&#8220;By launching a DEX from Nevada, we are looking to set a global standard; not just for cryptocurrency access, but for transparency and innovation across global financial systems.&#8221;
See Also: <a href="https://www.benzinga.com/insights/short-sellers/25/07/46202658/what-does-the-market-think-about-stifel-financial">What Does the Market Think About Stifel Financial?</a>
GPUS Price Action: At the time of publication, Hyperscale Data shares were up 2.14% at $1.43, according to data from <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/pro/&amp;ved=2ahUKEwiV04e7lZyOAxUbMlkFHe6cCQsQFnoECA4QAQ&amp;usg=AOvVaw0xIsPvjIcIIsWev01-6zR2">Benzinga Pro</a>.
Image: This illustration was generated using artificial intelligence via Midjourney.

GPUS

Hyperscale Data (GPUS) Stock Rises On Plans To Launch Decentralized Cryptocurrency Exchange

When a woman received a letter from the <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/06/46131760/i-thought-i-could-still-work-a-little-retiree-hit-with-surprise-9648-social-security-overpayment-notice">Social Security Administration</a> claiming she owed $4,765 due to excess earnings, she was understandably confused. After all, she thought she had followed the rules when she started collecting benefits early and continued working. But could a lesser-known rule — the "monthly earnings test" — help her reduce or even eliminate that overpayment?
Here's what to know if you're facing a similar situation.
<h2 class="wp-block-heading">What Triggered the Overpayment?</h2>
According to the individual's <a href="https://www.reddit.com/r/SocialSecurity/comments/1li3pll/ss_says_they_over_paid_mehelp/">Reddit post</a>, she began receiving Social Security retirement benefits at age 64 — before reaching full retirement age. She reached her FRA of 66 years and eight months in January.&nbsp;&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.</li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
In 2024, she earned $32,322 from working. That's more than the annual earnings limit for someone younger than FRA, which was $22,320 in 2024.
When early claimants earn above the limit, the SSA withholds $1 in benefits for every $2 earned over that threshold. Based on her income, she exceeded the limit by about $10,000, triggering a benefit reduction of around $5,000 — consistent with the amount SSA says she must repay.
<h2 class="wp-block-heading">What Is the Monthly Earnings Test — and Can It Help?</h2>
The woman asked whether the monthly test could be applied to her situation. The monthly earnings test, also called the special rule, is designed for people in their first year of retirement who earn less than a certain amount in specific months.
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
In 2024, the monthly earnings limit was $1,860. If a retiree earned less than that in a month, they could be eligible to keep their full benefit for that month — even if their total annual income exceeds the yearly limit. However, this rule typically only applies during the first year a person retires.
Since the Reddit poster retired a couple of years prior, she likely wouldn't qualify for the monthly test in 2024. In that case, only the annual limit would apply.
<h2 class="wp-block-heading">What Happens the Month You Reach Full Retirement Age?</h2>
Another source of confusion came from when the Reddit poster believed she reached her full retirement age in 2024. She initially thought it was in November, when she turned 66 years and 6 months. However, her actual FRA was January, at 66 years and 8 months, based on her birth year — something she later realized.
This matters because the SSA stops counting your earnings against your benefit starting the month you reach full retirement age. From that point forward, any income you earn no longer reduces your Social Security payments.
If the SSA had mistakenly included income from after she reached her true FRA as part of the overpayment calculation, that would be an error that she could appeal. However, as she learned, she didn't reach her FRA until this year.&nbsp;
See Also: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<h2 class="wp-block-heading">What Should You Do If You Get a Letter Like This?</h2>
If you receive an <a href="https://www.benzinga.com/personal-finance/tax/25/06/46067538/i-assumed-it-was-a-scam-letter-at-first-social-security-claims-woman-was-overpaid-by-20491-after-making-275k-last-year">overpayment notice</a>, you have several options:
<ul class="wp-block-list">
<li>Review your earnings and compare them to the SSA thresholds, calculating month by month if it's your first year of retirement. </li>
<li>Make an appointment with your local SSA office to go over the details in person.</li>
<li>Request a reconsideration if you believe the overpayment is a mistake.</li>
</ul>
If the SSA confirms the overpayment but repayment would cause hardship, you can ask for a repayment plan or file a <a href="https://www.ssa.gov/forms/ssa-632-bk.pdf">waiver request form</a>.
<h2 class="wp-block-heading">Bottom Line</h2>
Understanding how Social Security calculates benefit reductions can be complicated — especially when you&#8217;re working and approaching full retirement age. In this case, the Reddit poster likely didn't qualify for the monthly earnings test since it wasn't her first year of receiving benefits.
However, if you believe the SSA miscalculated your overpayment — by misapplying the monthly test or including income earned after your FRA — you have the right to question it. Reviewing your timeline and income carefully can make a big difference. And if repayment presents a <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/06/46067665/the-real-budget-killer-isnt-big-purchases-its-the-20-here-20-there-habits-that-quietly-empty-your-account">financial burden</a>, options like waivers and repayment plans are available.
Read Next: <a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a>
Image: Shutterstock

Personal Finance

Social Security Says She Owes $4,765 — But Could The Monthly Rule Save Her From Paying Back Money She Didn't Earn?

Shares of Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) are trading higher Tuesday after the companies reported strong <a href="https://www.benzinga.com/markets/tech/25/07/46187171/ford-ceo-jim-farley-praises-chinese-evs-amid-affordable-ev-platform-plans-its-the-most-humbling-thing">second-quarter sales</a>.
What To Know: Ford reported a 14.2% increase in second-quarter vehicle sales, significantly outpacing industry estimates and expanding its U.S. market share.
Ford highlighted broad-based strength across its truck, hybrid and SUV categories. The company's F-Series posted its best second quarter since 2019 with over 222,000 units sold, while electrified vehicle sales hit a record 82,886 units in the quarter. Ford also noted a 26% jump in Maverick sales and a 44.7% increase in its Bronco lineup. In total, Ford's second-quarter sales reached 612,095 units, up 14.2% year-over-year. 
"We blew the doors off the overall industry with our second-quarter sales," said Andrew Frick, president, Ford Blue and Model e, and interim head of Ford Pro.
GM, meanwhile, posted a 7% increase in U.S. sales for the second quarter and a 12% rise for the first half of 2025. Chevrolet and Buick drove much of the growth, with record crossover sales and continued dominance in full-size pickups and SUVs. GM also saw its EV sales double in the second quarter, making Chevrolet the best-selling EV brand and Cadillac the top luxury EV brand by market share during the quarter.
"The investments we have made in our crossovers, SUVs, and pickups – both gas and electric – along with great execution by our employees, suppliers and dealers, have made GM the engine of growth for the U.S. industry this year," said Duncan Aldred, GM senior VP and president of North America.
As both companies lean into a mix of combustion, hybrid and electric offerings, the results underscore the continued strength of U.S. consumer demand for pickups and SUVs. Investors responded positively to the strong execution and upward market share trends, sending both stocks higher on the day.
Price Action: Ford shares were up 4.54% at $11.33 and General Motors shares were up 5.24% at $51.80 at the time of writing Tuesday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/07/46200141/dow-jones-2025-first-half-scoreboard-top-10-winners-losers-where-do-nvidia-apple-stock-rank">Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?</a></li>
</ul>
Image via Shutterstock.

Ford, General Motors Shares Rise As Automakers Report Q2 Sales Growth

SoFi Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) shares are trading lower Tuesday afternoon, pulling back from Monday&#8217;s 52-week peak potentially amid profit-taking
The fintech company's stock surged throughout June, propelled by strategic announcements and bullish growth projections.
What To Know: Last week, SoFi <a href="https://www.benzinga.com/markets/tech/25/06/46117473/sofi-stock-gets-supercharged-with-return-to-crypto">revealed</a> its renewed cryptocurrency ambitions, planning to let members trade assets like Bitcoin and Ethereum later this year. The initiative will also feature crypto-backed loans and international money transfers. 
CEO Anthony Noto confirmed blockchain innovations would be integrated across all SoFi business lines, from investing to borrowing and payments.
This move builds on strong momentum from <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46174372/sofi-technologies-stock-hits-a-new-52-week-high-whats-going-on">earlier in June</a> when executives reaffirmed aggressive growth targets. At the William Blair Growth Stock Conference, CFO Chris Lapointe projected adjusted net revenue will exceed $3 billion by 2025, with annual growth surpassing 25% through 2026.
Analyst Ratings: While Wall Street analysts have presented a <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46174372/sofi-technologies-stock-hits-a-new-52-week-high-whats-going-on">range of views</a> on SoFi Technologies in recent months, the overall sentiment leans towards a constructive outlook.
Recent activity highlights this mixed but generally positive perspective. On June 2nd, Truist Securities initiated its coverage with a Hold rating, setting a price target of $14 per share.
This followed a series of analyst updates on April 30th. Barclays maintained its Equal-Weight rating while increasing its price target to $12 from $11. On the same day, UBS reiterated a Neutral stance but lifted its price target to a range of $14.00 to $15.50. 
In contrast, Needham expressed a more bullish view, reiterating a Buy rating and a $20 price target, suggesting a significant potential upside from current levels.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SOFI shares are trading lower by 2.9% to $17.68 Tuesday afternoon. The stock has a 52-week high of $18.92 and a 52-week low of $6.01.
Read Also: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/06/46156309/cathie-woods-ark-invest-continues-to-offload-coinbase-bets-big-on-sofi-technologies">Cathie Wood&#8217;s Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies</a>
<h2 class="wp-block-heading">How To Buy SOFI Stock</h2>
By now you're likely curious about how to participate in the market for SoFi Technologies &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of SoFi Technologies, which is trading at $17.68 as of publishing time, $100 would buy you 5.66 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

SOFI

Why SoFi Technologies Stock Was A Top Performer In June

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are trading lower Tuesday amid <a href="https://www.benzinga.com/news/politics/25/07/46187403/elon-musk-is-unhappy-with-trumps-big-beautiful-bill-and-just-reminded-everyone-that-80-voted-for-a-new-party">disagreements</a> between CEO Elon Musk and President Donald Trump. Additionally, Tesla registrations in Sweden and Denmark <a href="https://www.benzinga.com/markets/tech/25/07/46189042/elon-musk-led-teslas-european-woes-worsen-with-sales-down-over-60-in-sweden-and-denmark">fell during June.</a>
What To Know: The drop in Tesla shares follows Musk's vocal opposition to Trump's proposed federal spending bill, which Musk called a "disgusting abomination" on social media. Musk warned that if the bill passes, he would form a new political faction, the "America Party." In response, Trump criticized Musk's reliance on federal subsidies, implying Tesla&#8217;s survival is tightly linked to government support.
Investment advisor Ross Gerber <a href="https://www.benzinga.com/news/politics/25/07/46189313/ross-gerber-says-elon-musk-enabled-the-president-as-trump-slams-tsla-ceo-over-subsidies-calls-out-tesla-boards-silence-on-absurd-attack">criticized Tesla's board</a> for staying silent amid Musk's involvement in political discourse. Wedbush analyst Dan Ives added that the feud resembles a <a href="https://www.benzinga.com/markets/tech/25/07/46193084/tesla-stock-slump-tied-to-trump-musk-junior-high-school-friendship-gone-sour-says-dan-ives-but-predicts-it-will-settle-down">"junior high school friendship gone bad,"</a> predicting the situation would eventually stabilize but acknowledging near-term market discomfort.
Europe Woes Continue: In addition to political headwinds, Tesla's June registration data showed sharp declines in Sweden and Denmark, where year-over-year drops exceeded 60%. Meanwhile, France saw a 10% fall and Italy a staggering 66% plunge in registrations. The company did see strength in Norway, where Model Y deliveries surged 115% from a year earlier, leading to a 54% rise in overall Tesla sales in the region, according to Reuters.
Despite the<a href="https://www.benzinga.com/trading-ideas/movers/25/07/46193347/tesla-progress-software-dyne-therapeutics-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session"> release of a refreshed Model Y</a>, which began delivering in several European markets in June, analysts noted the impact appears insufficient to offset Tesla&#8217;s broader slide in Western Europe. According to Schmidt Automotive Research, Tesla has now posted six straight quarters of declining registration volumes in the region, with a potential seventh quarter underway.
Tesla is expected to report second-quarter delivery figures later this week, which could further test investor confidence amid growing uncertainty around Musk's leadership, product competitiveness and geopolitical positioning.
TSLA Price Action: Tesla shares were down 4.99% at $301.81 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46204187/palantir-stumbles-solar-stocks-rally-as-senate-approves-tax-bill-whats-moving-markets-tuesday">Palantir Stumbles, Solar Stocks Rally As Senate Approves Tax Bill: What&#8217;s Moving Markets Tuesday?</a></li>
</ul>
Image Via Shutterstock.

TSLA

What's Going On With Tesla Shares Today?

OVBC

Ohio Valley Banc Added To Broad-Market Russell 3000 Index

Innovator Capital Management, the company that launched the first <a href="https://www.benzinga.com/etfs">buffer ETF</a> back in 2018, introduced a new class of investment products that seek to produce positive returns in rising or declining markets. The Innovator Equity Dual Directional Buffer ETFs – July Series, launched on Tuesday, are the first ETFs of their kind that aim to potentially provide gains in both rising and declining markets over a one-year outcome period.
The Innovator Equity Dual Directional 10 Buffer ETF – July (BATS:<a class="ticker" href="https://www.benzinga.com/stock/DDTL#BATS">DDTL</a>) and the Innovator Equity Dual Directional 15 Buffer ETF– July (BATS:<a class="ticker" href="https://www.benzinga.com/stock/DDFL#BATS">DDFL</a>) track the performance of the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and utilize options to construct a specified outcome strategy. 
In a rising market, these products aim to match SPY's returns up to a preset cap. In a moderately declining market, they target the inverse of SPY's performance, also subject to a cap. Notably, they include a built-in buffer to limit losses during more severe market downturns.
For example, DDFL is structured such that if SPY drops 15% over the 12-month time frame, the ETF would return +15%, pre-expenses and fees. This is enabled through overlays of options that previously were limited to structured notes—expensive, intricate products historically reserved for institutional buyers.
Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/06/45801050/crash-proof-investing-new-innovator-etf-promises-downside-buffer">Crash-Proof Investing? New Innovator ETF Promises Downside Buffer</a>
<h2 class="wp-block-heading">What Makes These ETFs Stand Out</h2>
The Dual Directional Buffer ETFs bring together multiple compelling features:
Return potential both ways: Investors can capture gains whether the market rises or experiences moderate declines.
Predefined outcomes: Each ETF comes with an open upside cap, an inverse return cap, and a downside buffer, all of which are established before investment.
ETF structure benefits: Unlike structured products, these ETFs are liquid on a daily basis, transparent in pricing, tax-efficient, and carry no credit risk.
Clarifying the major differences between the two funds, DDTL offers a 10% cushion against market decline and has up to 12.59% potential upside if the market rises. In the event of a market downturn, it can have up to 10% in positive returns, similar to the inverse reaction of SPY within that limit. Conversely, however, DDFL provides a wider 15% buffer and has the potential to return as much as 15% in falling markets, and its upside cap is only slightly lower at 8.79%. Both funds have an expense ratio of 0.79%.
Innovator advises on over $25 billion of assets across more than 150 Defined Outcome ETFs as of May 31. The Dual Directional Buffer ETFs extend that tradition by bringing advanced risk-managed strategies to retail investors.
With volatility being a recurring theme in financial markets, these new ETFs aim to provide investors with something unusual: clarity, control, and the ability to win, regardless of market conditions.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/07/46204136/new-jpmorgan-etf-offers-a-different-route-to-income-investing">New JPMorgan ETF Offers A Different Route To Income Investing</a></li>
</ul>
Photo: Shutterstock

New ETFs

ETFs

Innovator ETFs Trust Innovator Equity Dual Directional 15 Buffer ETF - July

DDFL

Innovator ETFs Trust Innovator Equity Dual Directional 10 Buffer ETF - July

DDTL

Can You Profit When Markets Sink? Innovator's New ETFs Say Yes

HSBC has raised its <a href="https://www.benzinga.com/topic/gold">average gold price</a> forecast for 2025 to $3,215 an ounce, up from $3,015, citing "elevated geopolitical risks, economic uncertainty, and rising government debt." The bank also increased its 2026 estimate to $3,125 an ounce from $2,915, while projecting a turbulent path ahead.
"We anticipate a wide and volatile trading range of $3,600/oz to $3,100/oz for the rest of the year," HSBC said in a note, as reported <a href="https://www.reuters.com/business/hsbc-raises-average-gold-price-forecasts-2025-2026-2025-07-01/">by</a> Reuters.
Spot gold traded around $3,350 at 9:30 AM EST on Tuesday. The metal reached a record high of $3,500 in April, driven by surging demand from investors, <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43512109/gold-extends-records-as-central-banks-rush-to-buy-bullion-miners-eye-sixth-straight-winning-week">central banks</a>, and geopolitical hedgers.
However, while prices remain historically high, HSBC warned that additional gains above $3,500/oz may reduce physical demand, particularly for jewelry, coins, and small bars in markets such as India and China. Consumers are highly price-sensitive, and even modest spikes tend to dampen gold buying.
The shift in demand and a search for substitution have been evident in a recent surge in platinum's popularity. With gold jewelry becoming increasingly expensive, platinum has reached <a href="https://www.benzinga.com/markets/commodities/25/06/46138446/investors-seek-gold-alternative-platinum-hits-1400-as-supply-deficit-deepens">an 11-year high,</a> driven by rising consumer demand.
<h3 class="wp-block-heading">Safe-Haven Appeal</h3>
Ricardo Evangelista, senior analyst at ActivTrades, said gold's current trajectory remains supported by macro forces.
"The precious metal's safe-haven appeal is being boosted by concerns over the US fiscal outlook and ongoing tariff-related uncertainty," he <a href="https://www.reuters.com/world/india/gold-rises-weaker-dollar-tariff-uncertainty-before-deadline-2025-07-01/">told Reuters</a>, referring to President Donald Trump's pending <a href="https://www.benzinga.com/news/politics/25/06/46156587/trump-says-july-tariff-deadline-not-set-in-stone-we-can-do-whatever-we-want">July 9 tariff deadline</a>. "I expect prices to move higher in the near term&#8230; with the next significant resistance level around $3,370."
Global central bank demand, which surged over the last three years, remains a key pillar, although HSBC noted that buying may slow at prices above $3,300/oz. However, if gold retreats closer to $3,000, central banks could re-enter the market more aggressively, thereby reinforcing gold&#8217;s appeal as a reserve asset in uncertain times.
The combination of sticky inflation, a softening U.S. dollar, and deepening geopolitical divisions, especially in Eastern Europe and the Middle East, has also strengthened gold's position as a portfolio diversifier. HSBC clarifies that even if the rally pauses, gold's role as a long-term hedge remains intact.
In Canada, the gold rally has already had tangible market effects. The S&amp;P/TSX Composite Index surged 15% in U.S. dollar terms in the first half of the year, outpacing the S&amp;P 500, largely due to outsized gains in gold and silver miners.
"No doubt that it's been driven by gold. You need to have things that can bulletproof your portfolio, and gold is the one that does that the best,"&nbsp; Sadiq Adatia, chief investment officer at BMO Asset Management, said <a href="https://www.bloomberg.com/news/articles/2025-07-01/gold-helps-canada-s-stocks-benchmark-outshine-the-s-p-500">per</a> Bloomberg.
Still, Adatia warns that the second half of 2025 may not replicate the stellar gains of the first.
"I don't think gold is going to have the same run&#8230; a lot of the ambiguity and uncertainty has subsided," he noted.
Price Watch: SPDR Gold Trusts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) is up 27.19% year-to-date.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/m-a/25/07/46191888/chinas-largest-gold-mine-expands-in-central-asia-with-1-2-billion-acquisition">China&#8217;s Largest Gold Miner Expands In Central Asia With $1.2 Billion Acquisition</a></li>
</ul>
Photo: Shutterstock

Price Target

Commodities

Global

Economics

Markets

Analyst Ratings

HSBC Lifts Gold Forecast, Sees A Volatile Path Ahead

Intralot S.A. to Remain Listed on the Athens Stock Exchange
Transaction Enterprise Value of €2.7 Billion
Intralot S.A. (ATSE: INLOT) ("Intralot") and Bally's Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) ("Bally's") today announced that their respective Boards of Directors approved their entry into a definitive transaction agreement ("Transaction Agreement") pursuant to which Intralot will acquire Bally's International Interactive business (the "International Interactive Business") in a cash-and-shares transaction that values the International Interactive Business at an enterprise value of €2.7 billion (the "Transaction"). The consideration for the acquisition of the International Interactive Business will comprise a combination of cash paid by Intralot and newly issued shares delivered by Intralot to Bally's, as more specifically detailed below. As part of the Transaction, Intralot expects to refinance part of its existing debt facilities and Bally's also expects to repay secured debt from the cash proceeds.
The Transaction consideration to Bally's, after assumptions of certain liabilities by the involved parties, will (subject to certain agreed adjustments) be made up of:
<ul>
<li>€1.530bn cash consideration, and</li>
<li>€1.136bn of newly issued shares in new Intralot (873,707,073 shares, at an implied value of €1.30 per share).</li>
</ul>
In order to support the €1.530bn cash consideration to Bally's and refinance part of its existing debt, Intralot has obtained commitments from Citizens Bank, Deutsche Bank, Goldman Sachs, and Jefferies for debt financing up to €1.6bn (which is expected to be refinanced through the debt capital markets and is subject to certain conditions precedent) and expects to launch an up to €400mn share capital increase by way of an equity offering of shares listed on the Athens Stock Exchange, subject to corporate and regulatory approvals.
Following the completion of the Transaction, Intralot is expected to remain listed on the Athens Stock Exchange. Bally's, currently Intralot's largest shareholder, is expected to become the majority shareholder of Intralot as a result of the Transaction with a significant equity stake in Intralot. Intralot's founder, Mr. Sokratis Kokkalis, will maintain a significant stake in Intralot.
Following the completion of the Transaction, Intralot is expected to be a leading digital gaming operator and technology provider for lottery products with a footprint in some of the most attractive markets in Europe and North America. The combined technology capabilities of the two companies will allow Intralot to pursue new opportunities in gaming and lottery markets globally.
Intralot, following the completion of the Transaction, is expected to be among the largest companies by market capitalization listed on the Athens Stock Exchange.
The completion of the Transaction is expected to occur in the fourth quarter of 2025, subject to certain Intralot shareholder approvals, customary antitrust and gaming regulatory approvals and other customary closing conditions.
In connection with the Transaction, Bally's has secured commitments for a $500mn secured debt facility which, together with the cash proceeds from the Transaction, will be used to repay secured debt. In addition, Bally's has secured commitments for a $100mn delayed draw secured debt facility, which may be used following the consummation of the Transaction for general corporate purposes, including the development of Bally's Chicago.
Intralot has also today received notice that Bally's and its affiliates' ownership in Intralot has increased from 26.86% to 33.34%, following which a mandatory tender offer obligation for the remaining outstanding shares of Intralot has been triggered.

Intralot To Acquire Bally's International Interactive Business In €2.7B Cash-And-Shares Deal

Cryptocurrency markets saw modest declines as market sentiment turned cautious following the <a href="https://www.benzinga.com/markets/equities/25/07/46204187/palantir-stumbles-solar-stocks-rally-as-senate-approves-tax-bill-whats-moving-markets-tuesday">Senate's passage of the controversial Big Beautiful Bill</a>. The macro uncertainty combined with Bitcoin's ongoing range-bound technical structure is keeping momentum subdued.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$105,850.64</td>
</tr>
<tr>
<td>Ethereum</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,419.23</td>
</tr>
<tr>
<td>Solana</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$146.88</td>
</tr>
<tr>
<td>XRP</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.17</td>
</tr>
<tr>
<td>Dogecoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1583</td>
</tr>
<tr>
<td>Shiba Inu</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001114</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume increasing by 90.4% and daily active addresses growing by 32.1%. Transactions greater than $100,000 are up from 7,612 to 11,714 in a single day. Exchanges netflows expanded by 135.2%.</li>
<li>Coinglass data reports 91,656 traders were liquidated in the past 24 hours for $223.72 million.</li>
</ul>
Notable Developments:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46190931/bitcoin-ethereum-could-soon-help-you-get-a-mortgage-now-cathie-woods-ark-invest-sees-12-trillion-opportunity-after-fhfa-move">Bitcoin, Ethereum Could Soon Help You Get A Mortgage Now — Cathie Wood&#8217;s Ark Invest Sees $12 Trillion Opportunity After FHFA Move</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46194028/bitcoin-to-hit-200000-in-2025-but-new-eth-sol-highs-remain-in-doubt-bitwise-says">Bitcoin To Hit $200,000 In 2025, But New ETH, SOL Highs Remain In Doubt, Bitwise Says</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46201788/public-companies-are-quietly-building-massive-bitcoin-treasuries-faster-than-etfs-can-keep-up">Public Companies Are Quietly Building Massive Bitcoin Treasuries Faster Than ETFs Can Keep Up</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46178713/new-bitcoin-backed-stablecoin-vaults-offer-yield-strategies-without-requiring-btc-sales">New Bitcoin-Backed Stablecoin Vaults Offer Yield Strategies Without Requiring BTC Sales</a></li>
</ul>
Top Losers:
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
</tr>
<tr>
<td>SPX6900</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SPX</a>)</td>
<td>$1.11</td>
</tr>
<tr>
<td>Jito</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">JTO</a>)</td>
<td>$2.09</td>
</tr>
<tr>
<td>Dogwifhat</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>)</td>
<td>$0.7910</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: &nbsp;Crypto trader Jelle believes Bitcoin is currently testing the midpoint of a significant 8-year ascending channel. A confirmed breakout above the red dotted resistance line would mark a major technical shift and could invalidate prior bearish expectations, potentially setting the stage for an aggressive leg higher.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> still pushing into the midlevel of this 8-year-long channel. Break above the red dotted line, and all bets are off. &#x1f440;&#x1f680; <a href="https://t.co/WJS0xNU17N">pic.twitter.com/WJS0xNU17N</a>
&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1940047986865971512?ref_src=twsrc%5Etfw">July 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Byzantine General <a href="https://x.com/ByzGeneral/status/1940099582609780923">downplayed</a> fears around Bitcoin's recent drop, calling it a healthy liquidity sweep with strong volume and baseline-resetting funding rates. He sees a potential move to $104,000 as an optimal long entry, though a breakout rally could also launch from current levels.
CRG <a href="https://x.com/MacroCRG/status/1940116174743773362">noted</a> that the CME gap has been filled, but BTC has yet to show a strong bounce. It's sitting on a key support area but may dip further to run stops below the most recent swing low. However, there's also notable upside liquidity, and the 5-day inside bar high is acting like a magnet for price.
The consensus among these traders: early July dip buys may age well, though the exact bottom might still be slightly lower. The coming sessions could determine whether BTC confirms support or heads for one last sweep before lift-off.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46197054/bitcoin-enters-historically-weak-q3-with-mixed-feelings-report">Bitcoin Enters Historically Weak Q3 With Mixed Feelings: Report</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$JTO

$SHIB

$SOL

$SPX

$SYRUP

$WIF

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Dip But 'Early July Dip Buys Will Age Well,' Trader Says

Gold has quietly pulled off a rare feat in 2025, beating Bitcoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) returns in the first half of the year by <a href="https://www.benzinga.com/topic/gold">a double-digit margin. </a>
As of July 1, gold is up 26% year-to-date, marking its best half-year performance since 2007. Bitcoin has gained 13% over the same period.
Since Bitcoin's inception in 2009, gold has only outperformed it in three calendar years: 2014, 2018 and 2022. 
While each of those years saw triple-digit relative outperformance—125%, 285% and 178%—those gains came from steep Bitcoin selloffs, not explosive gold rallies.
With a 13% edge halfway through the year, could 2025 become the fourth year where gold decisively beats the world's top digital asset? 
<h2 class="wp-block-heading">Bitcoin Matures Amid Slower ETF Inflows</h2>
Bitcoin is emerging from a highly volatile and high-risk asset and showing signs of maturity in 2025.
During the tariff-driven selloff in early April, Bitcoin dropped by just 10%, holding up better than major equity benchmarks, such as the Nasdaq 100 and S&amp;P 500. 
"Bitcoin is shedding its punk status and moving into the mainstream," said Sumit Roy, senior analyst at ETF.com, in a recent note. He attributes this shift to declining price volatility and institutional adoption, especially through spot exchange-traded funds.
But with reduced volatility comes fewer explosive rallies.
Total inflows into iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) – the world&#8217;s largest Bitcoin ETF in the first half of 2025 – were $15 billion. 
That's strong, but down from the $17.7 billion recorded in the same period last year. 
The Fidelity Wise Origin Bitcoin Fund (CBOE: FBTC) – the second biggest Bitcoin ETF – drew just $285 million in new money versus $9.2 billion in the first half of 2024.
This is notable because recent political and regulatory developments have been overwhelmingly crypto-friendly.
<h2 class="wp-block-heading">Gold Takes The Lead As Dollar Crumbles</h2>
Investors appear to be taking a broader view, positioning gold as the clear winner in a weakening dollar environment.
The U.S. dollar just logged its worst half-year performance since 1991, with its trade-weighted value dropping more than 10% year to date.
Ed Yardeni, president of Yardeni Research, said President Donald Trump's ongoing attacks on Federal Reserve Chair Jerome Powell are rattling currency markets and accelerating the dollar's decline. 
"There is method to President Donald Trump's madness regarding Powell," Yardeni said. "He's found a way to effectively hammer the foreign-exchange value of the dollar—by hammering Powell."
Trump, who has long favored a weaker dollar to boost exports, is reportedly pressuring Powell to resign so he can install a more dovish successor. 
Potential replacements include Fed Governor Christopher Waller and Treasury Secretary Scott Bessent, both known for advocating quicker rate cuts.
As real yields fall and the dollar erodes, gold has now soared to $3,360 per ounce. Yardeni sees more upside ahead, targeting $4,000 by year-end—a gain of nearly 20% from current levels.
Wall Street, take notice: the original store of value is back in the spotlight.
Read now: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46194043/apple-stock-analysis-july-sp500-seasonality">Apple Stock Had A Nightmare Year — But It May Be Nearing A Turning Point</a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Regulations

Specialty ETFs

Federal Reserve

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

IBIT

Gold Rarely Beats Bitcoin, But 2025 Could Be Another Blowout Year

Whales with a lot of money to spend have taken a noticeably bullish stance on Regeneron Pharmaceuticals.
Looking at options history for Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 0% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $777,330 and 7, calls, for a total amount of $257,536.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $680.0 for Regeneron Pharmaceuticals over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Regeneron Pharmaceuticals's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Regeneron Pharmaceuticals's substantial trades, within a strike price spectrum from $300.0 to $680.0 over the preceding 30 days.
<h3>Regeneron Pharmaceuticals Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751396669_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/20/26</td>
<td>$71.0</td>
<td>$65.1</td>
<td>$68.1</td>
<td>$560.00</td>
<td>$340.4K</td>
<td align="right">0</td>
<td align="right">50</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$155.4</td>
<td>$149.3</td>
<td>$152.6</td>
<td>$680.00</td>
<td>$183.1K</td>
<td align="right">25</td>
<td align="right">12</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$132.3</td>
<td>$125.5</td>
<td>$128.0</td>
<td>$650.00</td>
<td>$64.0K</td>
<td align="right">64</td>
<td align="right">5</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/20/26</td>
<td>$61.8</td>
<td>$54.9</td>
<td>$58.76</td>
<td>$530.00</td>
<td>$58.7K</td>
<td align="right">12</td>
<td align="right">20</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/20/26</td>
<td>$62.1</td>
<td>$54.8</td>
<td>$58.45</td>
<td>$530.00</td>
<td>$58.4K</td>
<td align="right">12</td>
<td align="right">20</td>
</tr>
</tbody>
</table>

<h3>About Regeneron Pharmaceuticals</h3>
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
Having examined the options trading patterns of Regeneron Pharmaceuticals, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Regeneron Pharmaceuticals's Current Market Status</h3>
<ul>
<li>With a trading volume of 767,808, the price of REGN is up by 2.65%, reaching $538.89.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 31 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Regeneron Pharmaceuticals</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $673.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Regeneron Pharmaceuticals, targeting a price of $650. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Regeneron Pharmaceuticals, targeting a price of $560. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Regeneron Pharmaceuticals, which currently sits at a price target of $800. 
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Regeneron Pharmaceuticals, maintaining a target price of $755. 
&#x2A; An analyst from BMO Capital persists with their Outperform rating on Regeneron Pharmaceuticals, maintaining a target price of $600. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Regeneron Pharmaceuticals, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

REGN

Regeneron Pharmaceuticals Unusual Options Activity For July 01

Deep-pocketed investors have adopted a bearish approach towards Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in XYZ usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 16 extraordinary options activities for Block. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 31% leaning bullish and 43% bearish. Among these notable options, 3 are puts, totaling $107,036, and 13 are calls, amounting to $2,076,021.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $55.0 to $100.0 for Block over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Block stands at 3741.86, with a total volume reaching 10,318.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Block, situated within the strike price corridor from $55.0 to $100.0, throughout the last 30 days.
<h3>Block Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751396664_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$6.45</td>
<td>$6.35</td>
<td>$6.36</td>
<td>$65.00</td>
<td>$766.9K</td>
<td>4.4K</td>
<td>2.5K</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.95</td>
<td>$13.75</td>
<td>$13.9</td>
<td>$60.00</td>
<td>$428.1K</td>
<td>2.7K</td>
<td>319</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$1.72</td>
<td>$1.64</td>
<td>$1.64</td>
<td>$70.00</td>
<td>$331.4K</td>
<td>13.6K</td>
<td>2.1K</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$1.95</td>
<td>$1.88</td>
<td>$1.91</td>
<td>$100.00</td>
<td>$191.0K</td>
<td>8.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$2.41</td>
<td>$2.3</td>
<td>$2.4</td>
<td>$66.00</td>
<td>$56.9K</td>
<td>201</td>
<td>268</td>
</tr>
</tbody>
</table>

<h3>About Block</h3>
Founded in 2009, Block provides payment services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. In 2024, Square's payment volume was almost USD 250 million.
In light of the recent options history for Block, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Block's Current Market Status</h3>
<ul>
<li>Trading volume stands at 4,356,847, with XYZ's price up by 0.75%, positioned at $68.44.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>Expert Opinions on Block</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $68.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Truist Securities persists with their Sell rating on Block, maintaining a target price of $61. 
&#x2A; In a cautious move, an analyst from Piper Sandler downgraded its rating to Underweight, setting a price target of $50. 
&#x2A; Maintaining their stance, an analyst from Raymond James continues to hold a Outperform rating for Block, targeting a price of $79. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Block, maintaining a target price of $75. 
&#x2A; In a positive move, an analyst from Evercore ISI Group has upgraded their rating to Outperform and adjusted the price target to $75. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Block, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Check Out What Whales Are Doing With XYZ

Whales with a lot of money to spend have taken a noticeably bullish stance on Celsius Holdings.
Looking at options history for Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) we detected 18 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $413,166 and 13, calls, for a total amount of $735,885.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $12.5 to $52.5 for Celsius Holdings during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Celsius Holdings's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Celsius Holdings's whale trades within a strike price range from $12.5 to $52.5 in the last 30 days. 
<h3>Celsius Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751396658_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$1.68</td>
<td>$1.58</td>
<td>$1.68</td>
<td>$48.00</td>
<td>$167.5K</td>
<td>259</td>
<td>1.0K</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$9.85</td>
<td>$9.7</td>
<td>$9.8</td>
<td>$40.00</td>
<td>$147.0K</td>
<td>916</td>
<td>1</td>
</tr>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.2</td>
<td>$38.33</td>
<td>$124.4K</td>
<td>1.0K</td>
<td>389</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.95</td>
<td>$11.8</td>
<td>$11.9</td>
<td>$40.00</td>
<td>$101.1K</td>
<td>4.6K</td>
<td>85</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$7.5</td>
<td>$7.45</td>
<td>$7.5</td>
<td>$40.00</td>
<td>$75.0K</td>
<td>18.6K</td>
<td>195</td>
</tr>
</tbody>
</table>

<h3>About Celsius Holdings</h3>
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), Celsius On-the-Go powder packets, and the recently acquired portfolio of Alani Nu energy drinks and snacks. Celsius dedicates its efforts to branding and innovation, while it largely utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
Having examined the options trading patterns of Celsius Holdings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Celsius Holdings</h3>
<ul>
<li>With a volume of 4,806,805, the price of CELH is up 0.11% at $46.44. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 35 days.</li>
</ul>
<h3>Expert Opinions on Celsius Holdings</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $48.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on Celsius Holdings, maintaining a target price of $45. 
&#x2A; Reflecting concerns, an analyst from Stifel lowers its rating to Buy with a new price target of $47. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Celsius Holdings, maintaining a target price of $45. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Celsius Holdings, which currently sits at a price target of $50. 
&#x2A; Showing optimism, an analyst from TD Cowen upgrades its rating to Buy with a revised price target of $55. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Celsius Holdings options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

CELH

A Closer Look at Celsius Holdings's Options Market Dynamics

<a href="https://www.youtube.com/watch?v=czuxZsbndVk">https://www.youtube.com/watch?v=czuxZsbndVk</a>
&nbsp;

Comments

Aardvark Therapeutics

Aardvark Therapeutics (AARD) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL